metsera glp-1 Pfizer's hits mark for once-monthly dosing Metsera's Once Monthly GLP-1 Shot

Potency: Semaglutide typically demonstrates greater efficacy than native GLP-1 because it maintains a therapeutic concentration over a longer duration

This type of exercise improves glucose control by increasing fat oxidation, reducing abdominal fat, and building muscle mass

Recovery is the environment where training produces results

The glucagon component adds three distinct mechanisms: increased hepatic energy expenditure and thermogenesis (increasing resting metabolic rate by an estimated 100-200 kcal/day), enhanced hepatic fatty acid beta-oxidation (directly reducing liver fat), and lipolysis in both hepatic and adipose tissue

Incretin-based therapies for type 2 diabetes mellitus

However, in late 2017, a once-weekly GLP-1 diabetes drug hit the market, and people with diabetes now had the option of a weekly injection instead of a daily injection